Physician profile
Jon M Northam
NPI 1831190610
$1,577.48
in general payments reported to CMS, 2019-2025
21 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $28.67 · 2021: $49.34 · 2022: $286 · 2023: $404 · 2024: $257 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $879.43 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $372.38 | 2019-2025 | |
| Astellas Pharma US INC | $310.54 | 2022-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $181.09 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $148.12 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $117.97 | 2021-2022 | |
| Biogen, INC. | $83.47 | 2024-2025 | Zurzuvae |
| Amgen INC. | $79.04 | 2019-2024 | Prolia, Evenity |
| Pacira Pharmaceuticals Incorporated | $43.69 | 2022 | |
| Exact Sciences Corporation | $41.72 | 2025 | Cologuard Collection Kit |
| Scynexis, INC. | $20.14 | 2022 | |
| Hologic Sales and Service, LLC | $19.26 | 2025 | Myosure Tissue Removal Device, Novasure |
| Amag Pharmaceuticals, INC. | $18.84 | 2019 | |
| Coopersurgical, INC. | $18.77 | 2022 | |
| Organon LLC | $16.65 | 2024 | |
| Merck Sharp & Dohme LLC | $16.45 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $16.19 | 2024 | |
| Channel Medsystems, INC. | $15.89 | 2025 | |
| Therapeuticsmd, INC. | $15.82 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.66 | 2025 | Trintellix |
| Medtronic, INC. | $14.50 | 2025 | Ligasure |
| Daiichi Sankyo INC. | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Northam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.